NGM Bio Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
NGM Biopharmaceuticals (NGM) IPO Opens Lower
April 4, 2019 1:11 PM EDTToday's IPO for NGM Biopharmaceuticals (NASDAQ: NGM) opened for trading at $15 after pricing 6,666,667 shares of common stock at a price to the public of $16.00 per share.
In addition, NGM has granted the underwriters a 30-day option to purchase up to 1,000,000 additional shares... More
